EPLERENONE
Generic: EPLERENONE
Camber PharmaceuticalsManufacturer
ORALRoute
EPLERENONEActive Substance
2023-06-02Original Approval
EPLERENONE is FDA application ANDA213812, sponsored by ANNORA PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DYSPNOEA
933 reports
2
CARDIAC FAILURE
826 reports
3
ACUTE KIDNEY INJURY
809 reports
4
HYPOTENSION
740 reports
5
DIZZINESS
573 reports
6
FATIGUE
546 reports
7
OEDEMA PERIPHERAL
465 reports
8
DIARRHOEA
463 reports
9
DRUG INTERACTION
455 reports
10
DRUG INEFFECTIVE
413 reports